Generic Plavix Will Slow U.S. Pharmaceutical Sales Growth In 2006 – IMS
Executive Summary
The launch of generic Plavix (clopidogrel) could reduce overall pharmaceutical sales growth for 2006 by nearly one percent, IMS Health VP-Industry Relations Doug Long suggested